Prevention of relapse is a major goal of maintenance treatment in patients with psychotic disorders. We performed a long-term comparison of a newer, atypical antipsychotic drug, risperidone, and ...

Risperidone alters key brain regions in schizophrenia, with future imaging tools offering insights into its long-term effects ...

Risperidone (Risperdal, Janssen Pharmaceutica) was administered as 1-mg tablets; the dose was increased to 3 mg per day over the first 15 days.

LYN-005 matched daily risperidone in exposure while maintaining stability and offering a convenient long-acting option for ...

This multicenter, double-blind, randomized study evaluated the efficacy, safety and functional effects of two atypical antipsychotics, amisulpride and risperidone, in patients with chronic ...

Objective: To prospectively compare risperidone with conventional antipsychotic agents among schizophrenia patients treated under usual practice conditions. Design: One-year, multicentre, open ...

An oral, ultra-long-acting, extended-release risperidone capsule provided sustained therapeutic levels of risperidone over 1-week dosing intervals, according to results of a randomized, parallel ...

A Phase 3 clinical trial of a new once-weekly risperidone pill for schizophrenia shows it delivers comparable therapeutic effects to daily treatment, offering improved convenience and potential ...

Risperidone -- antipsychotic medicine normally prescribed to treat symptoms of schizophrenia and bipolar disorder -- may not be effective in treating symptoms of chronic post-traumatic stress ...

Teva announces positive real-world outcomes for UZEDY® and TEV-'749 in schizophrenia treatment, highlighting improved adherence and reduced hospital visits.

Risperidone and olanzapine were found to be equally effective for the treatment of persistent delusional disorder (PDD), according to a study published in Psychiatry Research.